Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by Aprilstocksgoupon Dec 05, 2022 8:49pm
241 Views
Post# 35152360

Sunday movies....thanks for posting

Sunday movies....thanks for postingbut please enlighten us on why this is such a steal at these prices???  We got Fast track status on mBC awhile back...it did zip for the shares...so why will Fast track on Panc be any different.  The panc studies were done on tiny numbers of patients....there is some question about whether the results can be projected on to larger populations. And the results were only good because there is an unmet need here....the actual improvements in the patients were small and incremental.  Yes pela is safe and has some effect...but we are not curing cancer here.    Canada always says the BPs have done a ton of due diligence on our company...but he is way exaggerating the implications of this....these BPs are just allowing us to play around with their drugs in controlled studies.....they do this with hundreds of small bios.  Phase III is still a ways off for both panc and MBc....phase III is typically when the BPs will start taking notice...I understand the BPS may want to run the phase III...and may acquire us...in fact that has to happen because we are running out of cash....of course the company keeps hitting the ATM anytime the stock moves up a few cents and that keeps the stock from running to any decent degree....i am just not seeing any urgency to buy here and the market seems to agree,,,volume and stock appreciation are minimal....sure we have had a small run of late....but most of us are stuck in this issue at much higher prices.....this forum is dominated by pumpers who have been sitting here for decades in many cases....it took a while for the scales to fall from my eyes on this issue 
<< Previous
Bullboard Posts
Next >>